Risk Of Developing Liver Cancer After HCV Treatment

Sunday, March 3, 2013

ClinicalThought™: Hepatitis Highlights

When education-related information on hepatitis C becomes available this blog points the reader to the new learning activity. Last month over at CCO a new module became available highlighting viral hepatitis.

CCO provides online interactive, and live continuing medical education (CME) programs designed especially for healthcare providers. However, hepatitis C patients taking part in these open CME programs can tap into new data and acquire additional knowledge on HCV, the drugs undergoing clinical trials or those currently in clinical practice.

Requires free registration

ClinicalThought™: Hepatitis Highlights

Topics

• Hepatitis C: Screening Recommendations
• Hepatitis C: Deciding Whether to Biopsy
• Reducing HCV Mortality
• Use of IL28B in the Setting of HCV DAAs
• Impact of Setbacks in HCV Drug Development
• Management of Acute HCV Infection
• HCV PIs in Active Drug Users
• Use of HCV PIs in HCV/HIV Coinfection
• Anemia Management During HCV PI Therapy
• Eltrombopag for Thrombocytopenia in HCV-Infected Patients
• Hepatitis C: Clinical Trial Development
• Management of Hepatitis B

 Source - http://www.clinicaloptions.com/Hepatitis.aspx

No comments:

Post a Comment